FDA Stings Beehive Botanicals For Web Links That 'Fell Through The Cracks'

摘要

Beehive Botanicals, has endured product seizure, a complaint from FDA for making unapproved drug claims and potential damage to its reputation because it did not have a firm handle on all dimensions of its online business. The March 31 enforcement action against Haywood, Wis.-based Beehive Botanicals comes three years after FDA issued a warning letter asking the company to remove drug claims from its Web site and product labeling.